Leonteq Securities AG’s AbbVie ABBV Stock Holding History

Leonteq Securities AG’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$1.62M	–	1207
2022 Q4	$1.62M	Hold	10,000	–	–	0.06%	234
2022 Q3	$1.34M	Hold	10,000	–	–	0.05%	237
2022 Q2	$1.53M	Buy	+10,000	New	+$1.53M	0.06%	240
2022 Q1	–	Sell	-5,000	Closed	-$677K	–	1242
2021 Q4	$677K	Hold	5,000	–	–	0.02%	407
2021 Q3	$539K	Hold	5,000	–	–	0.02%	405
2021 Q2	$563K	Buy	+5,000	New	+$563K	0.03%	362

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Leonteq Securities AG's ABBV Position: Q2 2026 in Review

Leonteq Securities AG increased its AbbVie (ABBV) stake by 58% in Q2 2026, buying an estimated $437K and bringing the position to 5,558 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #220.

Leonteq Securities AG first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.92M in Q3 2022. 2,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Leonteq Securities AG held 5,558 shares of AbbVie worth $1.4M as of Q2 2026.
Leonteq Securities AG bought 2,030 AbbVie shares in Q2 2026, an estimated $437K.
AbbVie made up 0.05% of Leonteq Securities AG's portfolio in Q2 2026, its #220 holding.
Leonteq Securities AG first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
Leonteq Securities AG's AbbVie position peaked at $2.92M in Q3 2022.
2,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.